article thumbnail

Supply chain middlemen ‘pocket half of US branded medicine spending’

pharmaphorum

The report from Berkeley Research Group (BRG) – which was funded by the pharma industry trade group PhRMA – reveals a steady decrease in the proportion received by drugmakers from around 67% in 2013 to 49.5%

article thumbnail

Medicine and medical device shortages: what’s been done and what’s to do

Hospital Pharmacy Europe

The first version of a list of critical medicines was published in 2023, with the aim to prevent disruption and help track EU manufacturing capacity and ensure the security of supply and availability of critical medicines at the EU level. This platform is expected to be operational by early 2025.